The use of extracorporeal membrane oxygenation (ECMO) for adult patients has increased in recent years. A retrospective cohort study of adult patients undergoing ECMO was performed between 19 February 1985 and 10 October 1995 to evaluate nosocomial infections. Seventy-one evaluable patients underwent ECMO for a total of 799 days. Forty-six infections were identified in 32 (45%) of 71 patients. There were 15 bloodstream infections, 13 lower respiratory infections, 11 urinary tract infections, and 7 miscellaneous infections. The rates of bloodstream infection (18.8 cases per 1,000 ECMO days) and urinary tract infection (13.8 cases per 1,000 ECMO days) were significantly higher than those reported through the Centers for Disease Control and Prevention/ National Nosocomial Infection Surveillance System (P õ .0001 and P õ .001, respectively). The rate of bloodstream infection increased with the duration of ECMO cannulation. This study highlights the increased risk for nosocomial infections in this patient population. Infection may not be apparent, and increased physician awareness of infection risk is imperative.
The use of extracorporeal membrane oxygenation (ECMO)
Materials and Methods is well established in neonatal respiratory failure and pediatSetting and patients. The University of Michigan Hospital ric cardiorespiratory failure [1 -4] . Experience with adults is a tertiary care center for adults that has Ç850 beds. The undergoing ECMO is more limited, but it has been used surgical intensive care unit (ICU) is a 20-bed unit that cares for select adults with respiratory failure who could not be for patients from multiple surgical services, including adult oxygenated adequately through conventional methods [5 -8] .
ECMO patients. The first adult patient underwent ECMO at The use of ECMO for adults at the University of Michigan the University of Michigan Hospital starting on 19 February Hospital (Ann Arbor) has increased in recent years, primarily 1985. All patients 17 years of age or older who underwent since a phase 1 study to evaluate ECMO for adult cardiorespi-ECMO in a surgical ICU for a minimum of 3 days between ratory failure began in 1988 [7, 8] . Since the care of adults 19 February 1985 and 10 October 1995 were eligible for evaluwith cardiorespiratory failure is intensive and invasive, this ation. Patients who underwent ECMO for õ3 days were not group of patients may be at increased risk of developing included in the study since they were not exposed to ECMO nosocomial infection. One recently reported article about the long enough to identify ECMO-related infections. occurrence of nosocomial infection in ECMO patients inAll patients were cared for using standardized ECMO procecluded neonates only [9] .
dures, which did not change over the study period. Antibiotic This retrospective cohort study was conducted to identify therapy was administered at the discretion of the treating physinosocomial infections that developed in an adult population cian and was based on the patient's presenting infection during the time that they underwent ECMO, evaluate their risk and/or infections identified during ECMO. Standardized proof developing nosocomial infection by comparing the infection phylactic or selective decontamination antibiotic regimens were rates among these patients with those reported through the not used. All microbiological cultures were performed at the Centers for Disease Control and Prevention/National Nosocodiscretion of the treating physicians. mial Infection Surveillance (CDC/NNIS) System, identify any Data collection. A retrospective cohort study was perfactors that may be associated with an increased risk of develformed through review of medical records. Microbiology and oping nosocomial infection, and identify the clinical characterinfection control service records were also reviewed to asceristics that were associated with the infections. tain infections. Infections were defined according to CDC/NNIS System definitions [10, 11] . Infections were recorded if they occurred during the period starting 24 hours 
Results
The complete medical records for 71 of 89 eligible patients were available and evaluated. The 71 patients underwent (26.7%) of 15 BSIs, were the most common bloodstream isolates; Enterococcus species, gram-negative bacilli, and Can-ECMO for a total of 799 days. All patients underwent mechanical ventilation and had urinary catheters and central catheters dida species were also associated with more than one BSI. The distribution of organisms associated with BSI in other patients for the same number of days as ECMO days. Forty-six nosocomial infections were identified in 32 (45%) of 71 patients.
in our surgical ICU during this same period was similar to the distribution seen for ECMO patients. Coagulase-negative There were 15 bloodstream infections (BSIs), 13 LRIs, 11 urinary tract infections (UTIs), and 7 miscellaneous infections staphylococci (46.8% of cases), Enterococcus species (9.3%), Candida albicans (9.3%), and coagulase-positive staphylococci (two venous catheter site infections and single episodes of clinical sepsis, pericarditis, hepatic abscess, mediastinitis, and (4.2%) were the major pathogens associated with BSI in all surgical ICU patients. The pathogens associated with LRI were sinusitis).
The demographic information for the 32 patients who develpredominantly gram-negative bacilli, with Pseudomonas aeruginosa isolated in six (46.2%) of 13 episodes. Candida species oped nosocomial infection and the 39 patients without nosocomial infection is shown in table 1. There were no statistically were isolated in eight (72.8%) of 11 episodes of UTI in ECMO patients, and with gram-negative bacilli were isolated in the significant differences between the groups in terms of age, sex, underlying conditions, cause of respiratory failure, duration of remaining three cases. The major pathogens associated with UTI in all surgical ICU patients during this period were differmechanical ventilation before initiation of ECMO, and APACHE II score. Infected patients were hospitalized in our ent from those associated with UTI in ECMO patients: P. aeruginosa (20% of cases), Enterococcus species (19%), institution before ECMO a mean of 2.3 days (range, 0 -17 days), which was not significantly different than the duration Escherichia coli (12%), and Candida species (8.6%). The rates of BSI, LRI, and UTI among the ECMO patients for uninfected patients (mean, 1.6 days; range, 0 -16 days).
The organisms associated with BSI, LRI, and UTI are listed were compared with the CDC/NNIS System rates of BSI, pneumonia, and UTI among surgical ICU patients ( figure 1) 
NOTE. BSI Å bloodstream infection; ECMO Å extracorporeal membrane oxygenation; LRI Å lower respiratory infection; UTI Å urinary tract infection. * Seventeen microorganisms were isolated in 15 BSI episodes (two were polymicrobial). † Seventeen microorganisms were isolated in 13 LRI episodes (three were polymicrobial).
The rate of BSI among ECMO patients was 18.8 cases per 1,000 13.8 cases per 1,000 urinary catheter days, compared with the ECMO days, which was significantly higher than the CDC/NNIS CDC/NNIS System rate of 5.6 cases per 1,000 urinary catheter System rate of BSI among surgical ICU patients of 5.1 cases days among surgical ICU patients (P õ .001). Among all paper 1,000 central catheter days (P õ .0001). The average rate tients in our surgical ICU between 1988 and 1995, the rate of of BSI among all patients in our surgical ICU between 1988 nosocomial UTI was 2.4 cases per 1,000 urinary catheter days. and 1996 was 4.1 cases per 1,000 central catheter days.
An analysis of the rate of BSI as a function of the duration The rate of LRI was 16.3 cases per 1,000 mechanical ventilaof ECMO was also performed (figure 2). Among patients who tor days, which was not significantly different from the underwent ECMO for 3 -10 days, the rate of BSI was 9.5 cases CDC/NNIS System rate of pneumonia of 14.9 cases per 1,000 per 1,000 ECMO days (five BSIs in 525 ECMO days). Among ventilator days. The rate of UTI among the ECMO patients was patients who underwent ECMO for 11 -20 days and 21 -30 days, the rates of BSI increased to 27.2 cases per 1,000 ECMO days and 64.5 cases per 1,000 ECMO days, respectively. The highest rate of BSI, 90.9 cases per 1,000 ECMO days, occurred among patients who underwent ECMO for a 31-to 40-day period. BSI did not occur in the only patient who underwent ECMO for ú40 days (57 days). The 15 BSIs occurred an average of 15.7 days (range, 5 -32 days) after the initiation of ECMO. Eight (53%) of the 15 patients had documented fever on the day of bacteremia. Only five (33%) of the 15 patients had documented worsening of their hemodynamic status. The WBC cell counts were elevated (ú10,000/mL) in 12 (86%) of 14 patients. However, the WBC cell count was increased over those documented on previous days for only four patients.
Thirteen LRIs were diagnosed an average of 9.8 days (range, 4 -27 days) after ECMO was instituted. All 13 patients had purulent sputum. Three (23%) of the 13 episodes were accompanied by documented fever. Four (31%) of the 13 patients Five (39%) of the 13 patients had radiographic evidence of (ᮀ) compared with pooled mean rates of BSI, pneumonia, and UTI worsening conditions. The WBC cell count was elevated in among surgical intensive care unit patients that were reported through seven of 10 patients, but only one patient's WBC cell count insertion, and duration of catheterization [16, 17] . The rate of dergoing extracorporeal membrane oxygenation (ECMO) that were BSI among ECMO patients in this study significantly exceeded stratified by duration of ECMO.
the CDC/NNIS System rate among surgical ICU patients and other patients within our surgical ICU [12] . ECMO patients generally have multiple indwelling catheters, such as pulmoThe 11 UTIs occurred an average of 10.3 days (range, 4-24 nary artery catheters and radial artery catheters, in addition to days) after ECMO was instituted. Fever was documented at the the cannulas used for the ECMO circuit. The contribution of time of UTI in two (18%) of the episodes. Eight patients were each type of catheter to the increased rate of BSI among these asymptomatic; one had fever as the only sign of infection. Two patients cannot be calculated. Our data indicate that the risk patients were septic, but each had a second infection (one had of BSI increases markedly with the duration of ECMO. This BSI, and one had LRI) that may have accounted for the sepsis.
finding is not unexpected, since an increased risk of BSI has Comparisons of all ECMO patients with and without nosocobeen associated with increased durations of indwelling vascular mial infection regarding clinical exposures revealed no significatheters [16 -19] . Other high-risk intravascular devices such cant differences. The use of propofol, perfluorocarbon liquid as intraaortic balloon pumps and left ventricular assist devices ventilation, H 2 receptor antagonists, urinary catheters, and nahave also been associated with nosocomial infections that corsogastric tubes was not statistically different between the two relate with the duration of device usage [20, 21] . groups. All patients received antibiotic therapy. Exposure to venoarterial ECMO did not differ significantly between the two groups. The use of continuous hemodialysis or ultrafiltration LRI, in our study, represents the CDC/NNIS System categoated with detrimental changes in these parameters. The ECMO patients also frequently had baseline leukocytosis, but the level ries of both pneumonia and LRI (not pneumonia). We categorized the patients in this manner because of the realization that of leukocytosis often did not change in association with nosocomial infections. Because of the frequent absence of clinical the diagnosis of pneumonia in these patients is difficult given the criteria that are included in the CDC definition of pneumosigns of infection and the marked increased risk of developing nosocomial BSI, random surveillance blood cultures may be nia [10] . Because of preexisting abnormalities on chest roentgenograms of ECMO patients, low-pressure ventilator settings prudent to identify these infections. The frequency with which these cultures should be performed requires further study. (to reduce barotrauma) that limit the value of lung auscultation, and limitations on the extent of physical examination that may In summary, ECMO patients are at increased risk of nosocomial infection when compared with other patients in the surgibe done, most patients do not fulfill the criteria for pneumonia in the CDC definition. We suspect that application of the cal ICU setting. These patients also lack many of the clinical signs and symptoms associated with nosocomial infections, CDC/NNIS System definitions to this population of patients results in underreporting of nosocomial pneumonia. These pathus making the diagnosis difficult; standard definitions for infections may not apply. More studies are needed to enhance tients would be expected to be at high risk of ventilator-associated pneumonia given their prolonged intubation, invasive caththe diagnosis of infections, better define risk factors for infection, and outline prevention strategies for this group of patients. eters, and frequent antibiotic therapy [22] .
The distribution of microorganisms causing nosocomial infections in ECMO patients differs from the distribution of microorganisms causing nosocomial infections in surgical ICU
